Nodular Sclerosis Hodgkin Lymphoma, Intrapelvic Lymph Nodes (C81.16)

Name of the Condition

• Common Name: Nodular Sclerosis Hodgkin Lymphoma
• Medical Terms: Nodular Sclerosis Hodgkin's Disease, NSHL

Summary

Nodular sclerosis Hodgkin lymphoma (NSHL) is a subtype of Hodgkin lymphoma defined by Reed-Sternberg cells and a fibrous nodular pattern in affected lymph nodes. This specific code (C81.16) indicates involvement of intrapelvic lymph nodes. NSHL is the most common subtype of Hodgkin lymphoma and typically presents with painless lymph node enlargement. It tends to affect young adults and has a favorable prognosis with standard treatment.

Causes

The exact cause of NSHL is not fully understood, but it is believed to result from a combination of genetic and environmental factors. Viral infections, such as Epstein-Barr virus (EBV), may contribute to its development, though not all cases are associated with EBV. Genetic predisposition and immune system interactions are also thought to play a role.

Risk Factors

• Age: Most commonly diagnosed in young adults (15-35 years) and adolescents.
• Gender: Slightly more prevalent in females.
• Family History: Having a first-degree relative with lymphoma may increase risk.
• Epstein-Barr Virus: Prior infection may elevate susceptibility.

Symptoms

• Painless swelling of lymph nodes, often in the pelvis or groin.
• Persistent fatigue or weakness.
• Unexplained fever or night sweats.
• Unintentional weight loss.
• Pruritus (itching).

Diagnosis

Diagnosis typically involves a combination of physical examination, imaging studies (e.g., CT or PET scans), and biopsy of the affected lymph node. Histopathological analysis confirms the presence of Reed-Sternberg cells and the characteristic nodular sclerosis pattern. Staging is performed to determine the extent of disease.

Treatment Options

Standard treatment includes chemotherapy, often with ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) or similar regimens. Radiation therapy may be used for localized disease. Stem cell transplantation is considered for relapsed or refractory cases. Treatment plans are tailored to the stage and individual patient factors.

Prognosis and Follow-Up

NSHL has a favorable prognosis, with high cure rates, especially in early-stage disease. Follow-up includes regular monitoring with imaging and clinical assessments to detect recurrence. Long-term survivors may require surveillance for late effects of treatment.

Complications

Potential complications include treatment-related toxicities (e.g., cardiopulmonary effects from radiation or chemotherapy), secondary malignancies, and infertility. Lymphedema or organ dysfunction may occur depending on the extent of disease or treatment.

Lifestyle & Prevention

No specific preventive measures exist, but maintaining overall health, avoiding known carcinogens, and managing stress may support general well-being. Vaccinations (e.g., against influenza) are recommended during treatment to reduce infection risk.

When to Seek Professional Help

Seek medical attention for persistent lymph node swelling, unexplained weight loss, fever, or night sweats. Prompt evaluation is important for early diagnosis and treatment.

Tips for Medical Coders

Use C81.16 for nodular sclerosis Hodgkin lymphoma involving intrapelvic lymph nodes. Ensure documentation specifies the anatomical location to support code assignment. Verify that the diagnosis aligns with histopathological confirmation of nodular sclerosis subtype.